TruBridge, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TBRG research report →
Range $23 – $26.25
Price Chart
About the company
TruBridge, Inc. delivers a comprehensive suite of healthcare solutions and services to community hospitals, clinics, and various medical facilities, both within the United States and globally. Its operations are structured around three core divisions: Revenue Cycle Management (RCM), Electronic Health Record (EHR), and Patient Engagement.
- CEO
- Christopher L. Fowler
- IPO
- 2002
- Employees
- 3,500
- HQ
- Mobile, AL, US
Get TickerSpark's AI analysis on TBRG
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $393.58M
- P/E
- 89.31
- Fwd P/E
- 9.83
- PEG
- 0.33
- P/S
- 1.14
- P/B
- 2.14
- EV/EBITDA
- 16.17
- Div Yield
- 0.00%
- Gross Margin
- 51.23%
- Op Margin
- 5.96%
- Net Margin
- 1.27%
- ROE
- 2.48%
- ROIC
- -54.87%
Latest fiscal year · YoY change
- Revenue
- $346.84M+1.2%
- Gross Profit
- $183.86M+5.6%
- Op Income
- $20.83M
- Net Income
- $4.35M+121.3%
- EPS
- $0.29+121.0%
- OCF Growth
- +15.0%
- FCF Growth
- +173.5%
- 52W High
- $26.51
- 52W Low
- $13.88
- 50D MA
- $26.04
- 200D MA
- $21.76
- Beta
- 1.29
- RSI (14)
- 79
- Avg Volume
- 326.41K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
TruBridge said 2025 finished with modest revenue growth, strong EBITDA and cash flow improvement, and expects 2026 to bring modest revenue growth plus about 200 basis points of adjusted EBITDA margin expansion despite no formal guidance.· April 1, 2026
- Q4 revenue was $87.2 million and adjusted EBITDA was $19.2 million, with full-year revenue of $346.8 million and adjusted EBITDA of $68.7 million.
- Full-year free cash flow was $20 million, up about $5 million year over year, and cash at quarter-end rose to $24.9 million.
- Bookings improved to $19.8 million in Q4 and pipeline hit a 9-quarter high, up 53% since the start of Q3, with a higher mix of recurring and larger deals.
- Management said the strategic review is ongoing with no timeline disclosed, and the company did not issue formal guidance.
- Customer retention on the CBO/RCM side remains a headwind, though management said transition processes are improving and modest revenue growth in 2026 assumes continued attrition pressure eases only gradually.
Q4 2025 total revenue was $87.2 million, about 1% lower year over year, while adjusted EBITDA was $19.2 million and adjusted EBITDA margin was 22%, up 160 basis points from 20.4% in Q4 2024. Full-year 2025 revenue was $346.8 million, up 1.4% year over year; adjusted EBITDA was $68.7 million, up 23%; full-year gross margin was not explicitly stated, but Q4 total gross margin was 53%, flat year over year and up 120 basis points sequentially. Full-year cash flow from operations was $37 million, up 19% year over year, free cash flow was $20 million, up about $5 million, cash ended at $24.9 million, and net debt was reduced to approximately $139.8 million with net leverage at 2x. Bookings were $19.8 million in Q4 on a TCV basis, $82.9 million for the full year, and ACV bookings were $70.9 million. Management did not provide formal guidance, but said it expects modest revenue growth in 2026 and approximately 200 basis points of adjusted EBITDA margin expansion.
Chris Fowler framed the year as a transition period with improved reporting discipline, ongoing strategic review, and operational progress. He emphasized that the business is seeing a healthier pipeline, better mix toward recurring deals and larger customers, and early signs that the global workforce transition model is becoming repeatable. He also highlighted AI initiatives across financial health, patient care, customer service, and internal development as tools to improve outcomes, speed product delivery, and support margin expansion.
Vinay Bassi focused on the financial repair and cash-generation story. He cited Q4 revenue of $87.2 million, Q4 adjusted EBITDA of $19.2 million, full-year revenue of $346.8 million, full-year adjusted EBITDA of $68.7 million, cash from operations of $37 million, free cash flow of $20 million, cash of $24.9 million, net debt of about $139.8 million, and net leverage of 2x. He said the 2026 margin expansion target of about 200 basis points should come from a combination of offshore transition, cost optimization, and revenue mix, and noted the new credit agreement extends maturity to 2030 with up to $250 million of facilities.
Analysts focused on how to think about bookings-to-revenue conversion, the pace of customer retention improvement, and the lack of formal guidance. Management said bookings need to be viewed alongside recurring revenue and attrition, that 2026 still reflects some attrition from 2025, and that there is no timeline for the strategic review. Questions also probed capacity constraints, margin upside, and whether AI or partnerships like RevSpring could change the earnings profile; management said there are no capacity constraints, margin expansion is not at the ceiling, and RevSpring should have little impact this year with more traction toward the back half and into 2027.
The positive case from the call is that pipeline strength, recurring-revenue mix, and larger-deal opportunities are all improving while bookings held up better in Q4. Management also pointed to stronger free cash flow, lower debt, a 2x leverage ratio, and multiple AI and product initiatives that could support both growth and margins over time.
The main risks discussed were customer retention pressure, especially in CBO/RCM transitions, and the fact that management still expects only modest revenue growth in 2026. The company also has no formal guidance, no timeline for the strategic review, and said bookings and revenue timing remain somewhat dependent on customer-driven implementation and contract-term dynamics.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 95.7%
- Shares Outstanding
- 15.00M
- Float Shares
- 14.35M
of shares held by institutions
93 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Glazer Capital, LLC | 1.20M | ▲ 1.20M |
| Nellore Capital Management LLC | 998.45K | ▲ 10.00K |
| Vanguard Group Inc | 744.71K | ▼ 10.67K |
| Alliancebernstein L.P. | 329.16K | ▲ 329.16K |
| Lmr Partners Llp | 225.26K | ▲ 225.26K |
| Sg Americas Securities, LLC | 204.75K | ▲ 204.75K |
| Oddo Bhf Asset Management Sas | 153.00K | ▲ 153.00K |
| Goldman Sachs Group Inc | 145.81K | ▼ 12.66K |
| Millennium Management LLC | 140.12K | ▲ 124.89K |
| Polar Asset Management Partners Inc. | 126.65K | ▲ 126.65K |
| D. E. Shaw & Co., Inc. | 113.69K | ▲ 57.58K |
| Northern Trust Corp | 102.22K | ▲ 11.46K |
Held by 9 ETFs
Biggest fund positions in TBRG by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 9, 26 | Pinetree Capital Ltd. | other | 2,130,000 |
| Jul 9, 26 | Pinetree Capital Ltd. | other | 850,000 |
| Jul 9, 26 | Leonard Damien | sell | 2,130,000 |
| Jul 9, 26 | Leonard Damien | sell | 850,000 |
| Jul 9, 26 | Anquillare Mark V | sell | 21,554 |
| Jul 9, 26 | Benjamin Regina M. | sell | 38,687 |
| Jul 9, 26 | Canada Jerry G Jr. | sell | 4,376 |
| Jul 9, 26 | Upitis Andris | sell | 1,114,178 |
| Jul 9, 26 | O'Keefe Amy K | sell | 7,561 |
| Jul 9, 26 | HJELM CHRISTOPHER T | sell | 31,591 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our TBRG coverage
Recent articles, reports, and earnings notes.
Want a deeper read on TBRG?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG
feeds.newsfilecorp.com · Oct 7
ROSEN, A LEADING LAW FIRM, Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG
newsfilecorp.com · Oct 6
TruBridge Investor News: If You Have Suffered Losses in TruBridge, Inc. (NASDAQ: TBRG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
globenewswire.com · Oct 5
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG
newsfilecorp.com · Oct 4
ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG
newsfilecorp.com · Oct 3
Rosen Law Firm Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG
prnewswire.com · Oct 2
ROSEN, A LONGSTANDING LAW FIRM, Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG
newsfilecorp.com · Sep 30
TruBridge Investor News: If You Have Suffered Losses in TruBridge, Inc. (NASDAQ: TBRG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
globenewswire.com · Sep 29
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
